Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10032762HBVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS10059189HBVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS30014568HIVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS30077154HIVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS30024844HIVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS20068134HPVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS44007688HTLV-1ENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS43000129MCVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TCGA Plot Options
Drug Information
GeneATP1A1
DrugBank IDDB16690
Drug NameTegoprazan
Target IDBE0010055
UniProt IDP54710
Regulation Typeinhibitor
PubMed IDs30843245
CitationsLee KJ, Son BK, Kim GH, Jung HK, Jung HY, Chung IK, Sung IK, Kim JI, Kim JH, Lee JS, Kwon JG, Park JH, Huh KC, Park KS, Park MI, Kim N, Lee OY, Jee SR, Lee SK, Youn SJ, Kim SK, Lee ST, Hong SJ, Choi SC, Kim TN, Youn YH, Park HJ, Kang MJ, Park CH, Kim BT, Youn S, Song GS, Rhee PL: Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis. Aliment Pharmacol Ther. 2019 Apr;49(7):864-872. doi: 10.1111/apt.15185. Epub 2019 Mar 6.
GroupsInvestigational
Direct Classification
SMILESCN(C)C(=O)C1=CC(O[C@H]2CCOC3=CC(F)=CC(F)=C23)=C2NC(C)=NC2=C1
Pathways
PharmGKB
ChEMBLCHEMBL4297583